- Report
- July 2026
- 193 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- March 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 378 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 479 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 277 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 455 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 464 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 370 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 166 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 398 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- June 2026
- 110 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- June 2026
- 150 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2026
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- April 2026
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more